Phenotypic homozygous familial hypercholesterolemia successfully treated
with proprotein convertase subtilisin/kexin type 9 inhibitors
- Ryosuke Tani
, - Keiji Matsunaga,
- yuta toda,
- Tomoko Inoue,
- hai fu,
- Tetsuo Minamino
Ryosuke Tani
Faculty of Medicine, Kagawa University, Cardiorenal and Cerebrovascular Medicine
Author Profilehai fu
Faculty of Medicine, Kagawa University, Cardiorenal and Cerebrovascular Medicine
Author Profile07 Nov 2023Submitted to Clinical Case Reports 09 Nov 2023Submission Checks Completed
09 Nov 2023Assigned to Editor
13 Nov 2023Reviewer(s) Assigned
15 Nov 2023Review(s) Completed, Editorial Evaluation Pending
21 Nov 2023Editorial Decision: Revise Minor
